Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.

Richardson MA, Bevans ML, Read LL, Chao HM, Clelland JD, Suckow RF, Maher TJ, Citrome L.

Am J Psychiatry. 2003 Jun;160(6):1117-24.

PMID:
12777270
2.

Branched chain amino acids decrease tardive dyskinesia symptoms.

Richardson MA, Bevans ML, Weber JB, Gonzalez JJ, Flynn CJ, Amira L, Read LL, Suckow RF, Maher TJ.

Psychopharmacology (Berl). 1999 Apr;143(4):358-64.

PMID:
10367552
3.

Treatment of tardive dyskinesia with vitamin E.

Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ.

Am J Psychiatry. 1992 Jun;149(6):773-7.

PMID:
1350428
4.

Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.

Bai YM, Yu SC, Lin CC.

J Clin Psychiatry. 2003 Nov;64(11):1342-8.

PMID:
14658949
5.

Factors in the development of severe forms of tardive dyskinesia.

Yassa R, Nair NP, Iskander H, Schwartz G.

Am J Psychiatry. 1990 Sep;147(9):1156-63.

PMID:
1974745
6.

Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.

Caroff SN, Walker P, Campbell C, Lorry A, Petro C, Lynch K, Gallop R.

J Clin Psychiatry. 2007 Mar;68(3):410-5.

PMID:
17388711
7.

The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.

Ganzini L, Heintz RT, Hoffman WF, Casey DE.

Arch Gen Psychiatry. 1991 Mar;48(3):259-63.

PMID:
1671743
8.

Is melatonin treatment effective for tardive dyskinesia?

Shamir E, Barak Y, Plopsky I, Zisapel N, Elizur A, Weizman A.

J Clin Psychiatry. 2000 Aug;61(8):556-8.

PMID:
10982197
9.

Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group.

Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caligiuri M, Tracy K.

Arch Gen Psychiatry. 1999 Sep;56(9):836-41.

PMID:
12892048
10.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
11.
12.

Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.

Libov I, Miodownik C, Bersudsky Y, Dwolatzky T, Lerner V.

J Clin Psychiatry. 2007 Jul;68(7):1031-7.

PMID:
17685739
13.

Branched chain amino acid treatment of tardive dyskinesia in children and adolescents.

Richardson MA, Small AM, Read LL, Chao HM, Clelland JD.

J Clin Psychiatry. 2004 Jan;65(1):92-6.

PMID:
14744176
14.

Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.

Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.

Am J Psychiatry. 2000 Feb;157(2):287-9.

PMID:
10671405
15.

Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients.

Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ, Caligiuri MP.

Am J Psychiatry. 1999 Feb;156(2):309-11.

PMID:
9989570
16.

Tardive dyskinesia and glucid metabolism.

Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.

Hum Psychopharmacol. 2007 Aug;22(6):373-80.

PMID:
17579925
17.

Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.

Pappa S, Tsouli S, Apostolou G, Mavreas V, Konitsiotis S.

Clin Neuropharmacol. 2010 Nov-Dec;33(6):271-5.

PMID:
21121175
18.

Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.

Loonen AJ, Verwey HA, Roels PR, van Bavel LP, Doorschot CH.

J Clin Psychopharmacol. 1992 Feb;12(1):39-42.

PMID:
1348061
19.

Comparison of severe and mild tardive dyskinesia: implications for etiology.

Gardos G, Cole JO, Schniebolk S, Salomon M.

J Clin Psychiatry. 1987 Sep;48(9):359-62.

PMID:
2887550
20.

Tardive dyskinesia and impaired glucose tolerance.

Chong SA, Mythily, Lum A, Huak CY, Kane J.

Hum Psychopharmacol. 2002 Aug;17(6):305-7.

PMID:
12404676

Supplemental Content

Support Center